WO2019187240A1 - Method for rapid identification of candida in which incomplete match probes are used - Google Patents
Method for rapid identification of candida in which incomplete match probes are used Download PDFInfo
- Publication number
- WO2019187240A1 WO2019187240A1 PCT/JP2018/036323 JP2018036323W WO2019187240A1 WO 2019187240 A1 WO2019187240 A1 WO 2019187240A1 JP 2018036323 W JP2018036323 W JP 2018036323W WO 2019187240 A1 WO2019187240 A1 WO 2019187240A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- candida
- probe
- pcr
- dna
- incomplete match
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
Definitions
- the present invention relates to a rapid identification method for Candida using an imperfect-match probe (IM probe).
- IM probe imperfect-match probe
- Candida species are the most common organisms of invasive fungal infections, causing widespread dissemination from local mucosal infections to multisystem organ failure. Recently, due to medical advances such as major surgery, especially abdominal surgery, dialysis and immunosuppressants, invasive candidiasis is increasing and is the fourth leading cause of nosocomial bloodstream infection in the United States.
- Candidaemia has an associated mortality rate of over 25%, and early appropriate antifungal therapy significantly reduces crude mortality.
- blood cultures take 2-5 days to be confirmed, treatment is greatly delayed.
- rapid and accurate information is required in order to target treatment according to sensitivity.
- Non-Patent Documents 1 and 2 In fungal infections, some studies report rapid identification of Candida species using melting Tm values (melting temperature values at which 50% of double-stranded DNA dissociates into single-stranded DNA).
- Non-Patent Documents 1 and 2 In these reports, the analysis of a single primer set was used to evaluate a clinical sample of candidemia.
- Tm mapping method for identifying a fingerprint as a fingerprint of a fungus (reflecting the difference in sequence) by collation with a database.
- the Tm mapping method can identify more than 100 bacterial species by using the melting temperature (Tm) of 7 primer sets, and results are obtained within 3 hours.
- Tm melting temperature
- Candida species are eukaryotic species such as humans, it is more difficult to design fungal-specific primers than bacteria. Moreover, it is cumbersome to prepare primers specific to each Candida species due to complexity, high cost, and the like.
- SMB Sloppy Molecular Beacon Melting Temperature Signature
- the inventors focused on molecular beacon technology, which is a kind of DNA probe, and tried to adapt a quenching probe that does not hydrolyze during PCR extension.
- the quenching probe tends to self-quenze by forming a secondary structure, an optimal probe that does not take a secondary structure with a delta G value was selected. Further research has been conducted, and it has been found that Candida species can be identified by a combination of Tm values obtained by three quenching probes, and the present invention has been completed. Hereinafter, the present invention will be described in detail.
- the rapid identification method of Candida using the incomplete match probe of the present invention is a rapid identification method of Candida that is performed in the following steps (FIG. 1).
- a process of extracting Candida DNA from a sample such as blood (2)
- Tm melting temperature
- Step (1) a step of extracting Candida DNA from a sample such as blood.
- Candida DNA is directly extracted from a clinical sample (such as a 2 mL whole blood sample) as a PCR template.
- the extraction method is not particularly limited, and known methods may be used for collecting clinical samples, extracting DNA, and the like. Here, it is preferable to use in combination with a bead method that enhances the extraction efficiency of bacterial nucleic acids and the like.
- Step (2) A step of performing PCR using the extracted Candida DNA as a template and using a Candida universal primer set and three incomplete match probes.
- the Candida universal primer set used in this step may be one set. For example, 20 to 25 base oligonucleotides that hybridize to the conserved region of Candida 18S ribosomal RNA (18S rRNA) are a set. Primers.
- the incomplete match probe is a 20-35 base oligonucleotide having three quenching functions for PCR apricon amplified from a conserved region of Candida 18S ribosomal RNA (18S rRNA). In three probes, the number of mismatches of one probe is 1 to 12. However, in the present invention, it is not necessary that all three probes have a mismatch. For example, if one probe has three mismatches, This includes cases where there is no need to mismatch the other two probes.
- thermostable DNA polymerase used for PCR in this step is preferably, for example, a thermostable DNA polymerase (KOD DNA polymerase) derived from the hyperthermophilic bacterium Thermococcus kodakarensis KOD1 strain in order to prevent the PCR efficiency from being lowered by a PCR inhibitor.
- PCR is performed using, for example, a mixture containing polymerase, dNTPs, forward primer, reverse primer and each probe, denaturing at 98 ° C. for 10 seconds, annealing at 57 ° C. for 30 seconds, extending at 72 ° C. for 20 seconds, and at 82 ° C. for 2 seconds. It is sufficient to perform a cycle such as fluorescence capture of about 50 cycles.
- Step (3) A step of obtaining (analyzing) a melting temperature (Tm) value of an incomplete match probe.
- Tm melting temperature
- the Tm value analysis after PCR is performed at 40 ° C. to 95 ° C. with an increase of 1 ° C./step.
- the Tm value may be obtained by analyzing the data profile using an analysis program (for example, Rotor-Gene Q software program, etc.) attached to the used Tm value analyzer.
- Step (4) A step of checking the Tm value with the database.
- Candida species are identified by comparing each Tm value to a database. Specifically, a preliminary database of eight Candida species representing the average value of three measurements of Tm values (FIG. 8) is created, and the target Candida species has the closest match to the known Candida species in the database. Identify by finding.
- the identification program is created in order to express each Tm value as a single point in the three-dimensional space. The distance between that point and the point determined for each of the known Candida species is calculated to generate a series of distance indicators, or difference values (D values) (FIG. 3).
- the Candida universal primer used in step (2) of the rapid identification method of Candida of the present invention may be designed so as to universally amplify the 18S ribosomal RNA gene of Candida.
- it may be designed and chemically synthesized using a multi-alignment software program (Clustal X).
- the Candida universal primer set used in this step may be one set.
- a primer composed of 20 to 25 nucleotide oligonucleotides corresponding to the conserved region of Candida 18S ribosomal RNA (18S rRNA) is used.
- S rRNA conserved region of Candida 18S ribosomal RNA
- Specific primers are as follows.
- the “quenching probe” of an imperfect-match quenching probe (IMQ probe) used for the incomplete match probe method has a function of “quenching” the fluorescence emitted from the excited fluorescent dye. Means ⁇ 35 base oligonucleotide.
- the number of mismatches of one probe is 1 to 12. However, in the present invention, it is not necessary that all three types of probes have a mismatch. For example, if there is a mismatch of three probes. This includes the case where there is no need to match the other two probes.
- the IMQ probe may be designed, for example, by selecting multiple sites of Candida 18S rRNA (accession number AF114470), designing using a multi-alignment software program (Clustal X), and chemically synthesizing.
- IMQ probes are as follows. ⁇ Probe 1> -5'-CTTTCCTTCTGGGTAGCCATTT--3 ': SEQ ID NO: 3 [22bp, binds to nucleotides 585-607 of C.albicans 18S rRNA (accession number AF114470) gene (probe is incompletely matched nucleotide sequence)] ⁇ Probe 2> -5'-TGGAATAATAGAATAGGACGTTATGGTTC-3 ': SEQ ID NO: 4 [29bp, binds to nucleotides 679-708 of C.albicans 18S rRNA (accession number AF114470) gene (probe is incompletely matched nucleotide sequence)] ⁇ Probe 3> -5'-GCATCAGTAATCAGTTGTCAGAGGAGAAATTC-3 ': SEQ ID NO: 5 [32bp, binds to nucleotides 758-790 of C. albicans 18S rRNA (a
- the detection / identification sensitivity of the Candida identification method of the present invention is 1.2 CFU C. albicans / PCR Tube (FIG. 9).
- a Candida blood pseudo blood sample was prepared by mixing 8 strains of Candida strains registered in the database into the blood of healthy subjects, and Candida species were detected and identified by the method of the present invention (FIG. 10).
- FIG. 10 A Candida blood pseudo blood sample was prepared by mixing 8 strains of Candida strains registered in the database into the blood of healthy subjects, and Candida species were detected and identified by the method of the present invention.
- FIG. 10 As a result, it was possible to accurately identify all 8 Candida species.
- Candida species were rapidly identified by the method of the present invention using 15 blood samples (3 species) of actual Candidaemia patients (FIG. 11). As a result, it was possible to accurately detect and identify Candida species in about 15 hours after blood collection in all 15 specimens.
- the three Tm values are defined as the position of one point in the three dimensions, and the distance between the two points with a known Candida bacterium in the database is represented as “Difference Value”. The closer this value is to zero, the more closely the detected bacteria match the Candida species in the database.
- Candida strains were identified at the species level by obtaining Candida strains from patient blood, sputum and urine culture isolates at Toyama University Hospital and sequencing them. Blood samples were whole blood collected from patients with Candidaemia at Toyama University Hospital and Nagasugi Hospital, and all procedures in the following examples were approved by Toyama University Ethics Committee and Nagasugi Hospital Ethics Committee and all The procedure was performed with written consent from the patient and the methods of the examples were performed according to approved guidelines.
- Candida colonies were collected in a sterile inoculation loop and suspended in 1 mL of molecular grade distilled water (deionized and sterilized distilled water for molecular biology, NACALAI TESQUE INC Kyoto Japan; hereinafter distilled water). The sample was then centrifuged at 20,000 ⁇ g for 10 minutes and 900 ⁇ L of supernatant was carefully removed so as not to lose the pellet. DNA was isolated from the resulting pellet using a DNA extraction kit (QIAamp UCP Pathogen Mini Kit, Qiagen, Germany) and glass beads according to the instructions in the product instructions. Finally, Candida DNA was eluted with 100 ⁇ L of elution buffer.
- molecular grade distilled water deionized and sterilized distilled water for molecular biology, NACALAI TESQUE INC Kyoto Japan; hereinafter distilled water.
- the sample was then centrifuged at 20,000 ⁇ g for 10 minutes and 900 ⁇ L of supernatant was carefully removed so as not to lose the
- PCR assay> Rotor-Gene Q (Qiagen) was used for target DNA amplification, real-time detection, and Tm value analysis of incomplete match probes. All PCR assays were performed as 1 PCR, 1 probe assay per tube. An Eppendorf tube dedicated to 1.5 mL PCR, which is a 0.2 mL PCR tube (Qiagen) for PCR of RNase and DNase free (Eppendorf, Germany), was used. A fungal universal primer targeting the known 18S ribosomal RNA gene (18S rDNA) was used (PLoS One. 2015; 10: e0129032). Quenching probes (Q probes) were designed using software (Clustal X) for creating various base sequence alignments and synthesized at NIPPON STEEL SUMIKIN Eco-Tech Corporation (Ibaraki, Japan).
- KOD FX Neo Toyobo
- the PCR reaction mixture (50 ⁇ L) consists of KOD FX Neo, 0.4 mM dNTP, and 0.02 U 1 ⁇ PCR buffer (included with KOD FX Neo: Toyobo), 0.2 ⁇ M forward primer, 0.6 ⁇ M reverse primer And 0.02 ⁇ M of each probe.
- Each sample was incubated at 95 ° C. for 5 minutes, then heat denatured at 98 ° C. for 10 seconds, annealed at 57 ° C. for 30 seconds, extended at 72 ° C. for 20 seconds, and subjected to fluorescence capture at 82 ° C. for 2 seconds. 50 cycles were carried out under the above PCR conditions.
- Tm value analysis the PCR tube containing each probe in the resulting PCR amplicon was heated at 95 ° C. for 10 seconds and then cooled at 40 ° C. for 90 seconds. Tm value analysis after PCR was performed at 40 ° C. to 95 ° C. with an increase of 1 ° C./step. The data profile was then analyzed using the Rotor-Gene Q software program to identify Tm values.
- ⁇ Analysis sensitivity test> One colony of C. albicans was cultured on Sabouraud dextrose agar for 48 hours, then scraped off the surface, suspended in phosphate buffered saline (PBS), and seeded again in the medium. To ensure pure culture of only one strain of Candida albicans, one colony was scraped again from the second medium after 48 hours, suspended in PBS and diluted 10-fold. Each dilution was divided into several aliquots. In order to evaluate the number of colonies (equivalent CFU / ml), the cells were plated on 3 sheets of Sabouraud dextrose agar. The detection limit (LOD) was determined by serially diluting DNA based on a known number of Candida albicans in PBS and measuring the presence or absence of PCR detection in each diluted sample.
- LOD detection limit
- Fungal primers targeting the known D1-D2 region and the internal transcription spacer (ITS) region were purified (QIAquick PCR Purification Kit; QIAGEN) and then sequenced (3500 Genetic Analyzer; Applied Biosystems).
- Bacterial species identification is performed using the BLAST nucleotide database tool of DNA Data Bank (http://www.ddbj.nig.ac.jp/index-j.html) and online nucleotide homology for bacterial species identification I did a search.
- the method for identifying Candida of the present invention uses one PCR primer set and three incomplete match probes to generate three Tm values and compare them with data registered in a database.
- Candidiasis (8 species) with candidiasis can be rapidly identified. The time required for identification is within 3.5 hours after blood collection. Since the new genetic testing method of the present invention can be carried out quickly and easily and inexpensively, it can be kitted as an in-vitro diagnostic agent and is medically useful.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Toxicology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
本発明は、不完全なマッチプローブ(imperfect-match probes:IMプローブ)を用いたカンジダ菌の迅速同定法に関する。 The present invention relates to a rapid identification method for Candida using an imperfect-match probe (IM probe).
カンジダ種は、浸潤性真菌感染症の最も一般的な生物であり、局所粘膜感染から多系統臓器不全による広範な播種を引き起こす。
最近、大手術、特に腹部手術、透析および免疫抑制剤などの医学の進歩のために、侵襲性カンジダ症が増加しており、米国では院内血流感染の第4位の原因である。
カンジダ血症は関連死亡率が25%以上であり、初期の適切な抗真菌療法は粗死亡率を有意に低下させる。
しかし、血液培養は確定するまでに2~5日かかるため、治療の実施が大幅に遅れる。
また、カンジダ種については感受性に応じた治療を目標とするために迅速かつ正確な情報を必要とする。
Candida species are the most common organisms of invasive fungal infections, causing widespread dissemination from local mucosal infections to multisystem organ failure.
Recently, due to medical advances such as major surgery, especially abdominal surgery, dialysis and immunosuppressants, invasive candidiasis is increasing and is the fourth leading cause of nosocomial bloodstream infection in the United States.
Candidaemia has an associated mortality rate of over 25%, and early appropriate antifungal therapy significantly reduces crude mortality.
However, since blood cultures take 2-5 days to be confirmed, treatment is greatly delayed.
In addition, for Candida species, rapid and accurate information is required in order to target treatment according to sensitivity.
真菌感染において、いくつかの研究では、融解Tm値(二本鎖DNAの50%が解離して一本鎖DNAになる温度(Melting temperature)の値)を用いてカンジダ種の迅速な同定が報告されている(非特許文献1、2)。
これらの報告では、1つのプライマーセットの分析を使用し、カンジダ血症の臨床検体での評価も行われている。
また、全ての細菌に共通な塩基配列領域をターゲットとして設計した細菌ユニバーサルプライマーを用い、得られた7つのPCR増幅産物のTm値を測定し、その7つのTm値の組合せ(=菌種による塩基配列の相違を反映する)を菌の指紋(finger print)として、データベースとの照合により同定する方法(Tmマッピング法)が報告されている。(特許文献1、2)
In fungal infections, some studies report rapid identification of Candida species using melting Tm values (melting temperature values at which 50% of double-stranded DNA dissociates into single-stranded DNA). (Non-Patent
In these reports, the analysis of a single primer set was used to evaluate a clinical sample of candidemia.
In addition, using bacterial universal primers designed with a base sequence region common to all bacteria as targets, Tm values of the seven PCR amplification products obtained were measured, and combinations of the seven Tm values (= bases by bacterial species) There has been reported a method (Tm mapping method) for identifying a fingerprint as a fingerprint of a fungus (reflecting the difference in sequence) by collation with a database. (
Tmマッピング法は、7種のプライマーセットの融解温度(Tm)を用いることによって100種以上の細菌種を同定することができ、3時間以内に結果が得られる。
しかし、カンジダ種はヒトのような真核生物種であるため、真菌特異的プライマーを細菌よりも設計することは難しい。
さらに、複雑さ、高価格などのために、各カンジダ種に特異的なプライマーを調製することは面倒である。
The Tm mapping method can identify more than 100 bacterial species by using the melting temperature (Tm) of 7 primer sets, and results are obtained within 3 hours.
However, because Candida species are eukaryotic species such as humans, it is more difficult to design fungal-specific primers than bacteria.
Moreover, it is cumbersome to prepare primers specific to each Candida species due to complexity, high cost, and the like.
DNAプローブの一種である分子ビーコン技術(Sloppy Molecular Beacon;SMB)を利用した融解温度シグネチャー技術(Sloppy Molecular Beacon Melting Temperature Signature)を用いた細菌単離物の迅速な同定が報告されている(非特許文献5)。
この報告では、6つのTm値を細菌分離株のシグネチャーとして使用し、6次元空間における2点間の距離としてTm値を用いて細菌分離株を同定しようと試みがなされている。
SMB融解温度シグネチャー技術におけるTmの変動は、不規則な分子ビーコンハイブリダイゼーションにおけるプローブ -標的ミスマッチの数および位置に依存する。
Rapid identification of bacterial isolates using Sloppy Molecular Beacon Melting Temperature Signature (Sloppy Molecular Beacon; SMB), a type of DNA probe, has been reported (Non-patented) Reference 5).
This report attempts to identify bacterial isolates using 6 Tm values as signatures of bacterial isolates and using the Tm value as the distance between two points in 6-dimensional space.
The variation in Tm in the SMB melting temperature signature technique depends on the number and location of probe-target mismatches in irregular molecular beacon hybridization.
発明者らは、DNAプローブの一種である分子ビーコン技術に着目し、PCR伸長中に加水分解しない消光プローブの適応を試みた。
該消光プローブは日本のDNAデータバンクで報告されたカンジダ種で十分に評価され、同じカンジダ種の複数の変異株の間で変異がない(=塩基配列が全く同じ)場所に対応して作成した。
また、消光プローブは二次構造を形成することで自己消光する傾向があるため、デルタG値で二次構造を取らない最適プローブを選択した。
さらに研究を進め、3つの消光プローブによるTm値の組み合わせにより、カンジダ種を同定できることを見出し、本発明を完成するに至った。
以下、本発明を詳細に説明する。
The inventors focused on molecular beacon technology, which is a kind of DNA probe, and tried to adapt a quenching probe that does not hydrolyze during PCR extension.
The quenching probe was fully evaluated in the Candida species reported in the Japanese DNA data bank, and was created corresponding to the place where there was no mutation (= same base sequence) between multiple mutants of the same Candida species. .
Moreover, since the quenching probe tends to self-quenze by forming a secondary structure, an optimal probe that does not take a secondary structure with a delta G value was selected.
Further research has been conducted, and it has been found that Candida species can be identified by a combination of Tm values obtained by three quenching probes, and the present invention has been completed.
Hereinafter, the present invention will be described in detail.
本発明の不完全なマッチプローブを用いたカンジダ菌の迅速同定法とは、以下の工程で行うカンジダ菌の迅速同定方法である(図1)。
(1)血液などの検体からカンジダ菌のDNAを抽出する工程。
(2)抽出したカンジダ菌DNAを鋳型とし、カンジダ菌のユニバーサルプライマーセットおよび3種の不完全なマッチプローブを用いてPCRを行う工程。
(3)不完全なマッチプローブの融解温度(melting temperature:Tm)値を取得する工程。
(4)Tm値をデータベースと照合する工程。
によりカンジダ菌を同定する方法。
The rapid identification method of Candida using the incomplete match probe of the present invention is a rapid identification method of Candida that is performed in the following steps (FIG. 1).
(1) A process of extracting Candida DNA from a sample such as blood.
(2) A step of performing PCR using the extracted Candida DNA as a template and using a Candida universal primer set and three incomplete match probes.
(3) A step of obtaining an incomplete match probe melting temperature (Tm) value.
(4) A step of checking the Tm value with a database.
To identify Candida by:
・工程(1):血液などの検体からカンジダ菌のDNAを抽出する工程。
臨床試料(2mLの全血試料など)からPCR用鋳型としてカンジダ菌DNAを直接抽出する。
抽出方法は、特に限定されず、臨床試料の採取、DNA抽出などは公知の方法を用いればよい。
ここで、細菌核酸等の抽出効率を高めるビーズ法を併用することが好ましい。
Step (1): a step of extracting Candida DNA from a sample such as blood.
Candida DNA is directly extracted from a clinical sample (such as a 2 mL whole blood sample) as a PCR template.
The extraction method is not particularly limited, and known methods may be used for collecting clinical samples, extracting DNA, and the like.
Here, it is preferable to use in combination with a bead method that enhances the extraction efficiency of bacterial nucleic acids and the like.
・工程(2):抽出したカンジダ菌DNAを鋳型とし、カンジダ菌のユニバーサルプライマーセットおよび3種の不完全なマッチプローブを用いてPCRを行う工程。
この工程で用いられるカンジダ菌のユニバーサルプライマーセットは、1セットであればよく、例えば、カンジダ菌の18SリボゾームRNA(18S rRNA)の保存領域にハイブリダイズする20~25塩基のオリゴヌクレオチドがセットとなったプライマーが挙げられる。
不完全なマッチプローブは、カンジダ菌の18SリボゾームRNA(18S rRNA)の保存領域を増幅したPCRアプリコンに対する3つの消光機能を有する20~35塩基のオリゴヌクレオドである。
3つのプローブにおいて、一つのプローブのミスマッチ数は、1~12であるが、本発明では、3つのプローブの全てにミスマッチがある必要はなく、例えば、一つのプローブに3つのミスマッチがあれば、他の二つのプローブにミスマッチなくてもよい場合も含むものである
Step (2): A step of performing PCR using the extracted Candida DNA as a template and using a Candida universal primer set and three incomplete match probes.
The Candida universal primer set used in this step may be one set. For example, 20 to 25 base oligonucleotides that hybridize to the conserved region of
The incomplete match probe is a 20-35 base oligonucleotide having three quenching functions for PCR apricon amplified from a conserved region of
In three probes, the number of mismatches of one probe is 1 to 12. However, in the present invention, it is not necessary that all three probes have a mismatch. For example, if one probe has three mismatches, This includes cases where there is no need to mismatch the other two probes.
本工程のPCRに用いられる熱安定性DNAポリメラーゼは、PCR阻害物質によるPCR効率の低下防止のため、例えば、超好熱菌Thermococcus kodakarensis KOD1株由来の耐熱性DNAポリメラーゼ(KOD DNAポリメラーゼ)が好ましい。
PCRは、例えば、ポリメラーゼ、dNTPs、順方向プライマー、逆方向プライマーおよび各プローブを含む混合物用い、98℃で10秒間変性、57℃で30秒間アニーリング、72℃で20秒間伸長、82℃で2秒間の蛍光捕捉といったサイクルを50サイクル前後行えばよい。
The thermostable DNA polymerase used for PCR in this step is preferably, for example, a thermostable DNA polymerase (KOD DNA polymerase) derived from the hyperthermophilic bacterium Thermococcus kodakarensis KOD1 strain in order to prevent the PCR efficiency from being lowered by a PCR inhibitor.
PCR is performed using, for example, a mixture containing polymerase, dNTPs, forward primer, reverse primer and each probe, denaturing at 98 ° C. for 10 seconds, annealing at 57 ° C. for 30 seconds, extending at 72 ° C. for 20 seconds, and at 82 ° C. for 2 seconds. It is sufficient to perform a cycle such as fluorescence capture of about 50 cycles.
・工程(3):不完全なマッチプローブの融解温度(melting temperature:Tm)値を取得(分析)する工程。
例えば、PCR後のTm値分析は、40℃~95℃で1℃/ステップで増加させて行う。 続いて使用したTm値分析機器付属の解析プログラム(例えばRotor-Gene Qソフトウェアプログラム、など)を用いてデータプロファイルを分析し、Tm値を取得すればよい。
Step (3): A step of obtaining (analyzing) a melting temperature (Tm) value of an incomplete match probe.
For example, the Tm value analysis after PCR is performed at 40 ° C. to 95 ° C. with an increase of 1 ° C./step. Subsequently, the Tm value may be obtained by analyzing the data profile using an analysis program (for example, Rotor-Gene Q software program, etc.) attached to the used Tm value analyzer.
・工程(4):Tm値をデータベースと照合する工程。
各Tm値をデータベースと比較することにより、カンジダ種を同定する。
具体的には、Tm値の3回測定の平均値を表す8種のカンジダ種の予備データベース(図8)を作成し、目的のカンジダ種は、データベース中の既知のカンジダ種と最も近いマッチを見つけることによって同定する。
ここで、識別プログラムは、各Tm値を3次元空間内の単一点として表現するために作成される。
その点と既知のカンジダ種のそれぞれについて決定された点との間の距離を計算して、一連の距離指標、または差値(D値)を生成する(図3)。
Step (4): A step of checking the Tm value with the database.
Candida species are identified by comparing each Tm value to a database.
Specifically, a preliminary database of eight Candida species representing the average value of three measurements of Tm values (FIG. 8) is created, and the target Candida species has the closest match to the known Candida species in the database. Identify by finding.
Here, the identification program is created in order to express each Tm value as a single point in the three-dimensional space.
The distance between that point and the point determined for each of the known Candida species is calculated to generate a series of distance indicators, or difference values (D values) (FIG. 3).
本発明のカンジダ菌の迅速同定法の工程(2)に用いるカンジダ菌ユニバーサルプライマーは、カンジダ菌の18SリボソームRNA遺伝子を普遍的に増幅するように設計すればよい。例えば、マルチアラインメントソフトウェアプログラム(Clustal X)を用いて設計し、化学合成すればよい。
この工程で用いられるカンジダユニバーサルプライマーセットは、1セットであればよく、例えば、カンジダ菌の18SリボゾームRNA(18S rRNA)の保存領域に対応する20~25塩基のオリゴヌクレオチドがセットとなったプライマーが挙げられる。
具体的なプライマーは以下とおりである。
・順方向:5'-CTTTCGATGGTAGGATAGTGG-3 ':配列番号1
[21bp、C.albicans 18S rRNA(アクセッション番号AF114470)遺伝子由来のヌクレオチド210-230]
・逆方向:5'-GCTTTCGCAGTAGTTAGTCTTC-3':配列番号2
[22bp、C.albicans 18S rRNA(アクセッション番号AF114470)遺伝子由来のヌクレオチド802-823]
The Candida universal primer used in step (2) of the rapid identification method of Candida of the present invention may be designed so as to universally amplify the 18S ribosomal RNA gene of Candida. For example, it may be designed and chemically synthesized using a multi-alignment software program (Clustal X).
The Candida universal primer set used in this step may be one set. For example, a primer composed of 20 to 25 nucleotide oligonucleotides corresponding to the conserved region of
Specific primers are as follows.
-Forward direction: 5'-CTTTCGATGGTAGGATAGTGG-3 ': SEQ ID NO: 1
[21 bp, nucleotides 210-230 from
-Reverse direction: 5'-GCTTTCGCAGTAGTTAGTCTTC-3 ': SEQ ID NO: 2
[22 bp, nucleotides 802-823 from
不完全なマッチプローブ法に用いる消光プローブ(imperfect-match quenching probes:IMQプローブ)の「消光プローブ」とは、励起された蛍光色素から放出される蛍光を「クエンティング:消光」する機能を持つ20~35塩基のオリゴヌクレオドを意味する。
3種のプローブにおいて、1つのプローブのミスマッチ数は、1~12であるが、本発明では、3種のプローブの全てにミスマッチがある必要はなく、例えば、一つのプローブ3つのミスマッチがあれば、他の2つのプローブにミスマッチなくてもよい場合も含むものである。
IMQプローブは、例えば、カンジダ菌18S rRNA(アクセッション番号AF114470)複数の部位を選び、マルチアラインメントソフトウェアプログラム(Clustal X)を用いて設計し、化学合成すればよい。
The “quenching probe” of an imperfect-match quenching probe (IMQ probe) used for the incomplete match probe method has a function of “quenching” the fluorescence emitted from the excited fluorescent dye. Means ~ 35 base oligonucleotide.
In the three types of probes, the number of mismatches of one probe is 1 to 12. However, in the present invention, it is not necessary that all three types of probes have a mismatch. For example, if there is a mismatch of three probes. This includes the case where there is no need to match the other two probes.
The IMQ probe may be designed, for example, by selecting multiple sites of
具体的なIMQプローブは、以下のとおりである。
<プローブ1>
・5'-CTTTCCTTCTGGGTAGCCATTT--3':配列番号3
[22bp、C.albicans 18S rRNA(アクセッション番号AF114470)遺伝子のヌクレオチド585-607部位に結合(プローブは不完全一致の塩基配列)]
<プローブ2>
・5'-TGGAATAATAGAATAGGACGTTATGGTTC-3':配列番号4
[29bp、C.albicans 18S rRNA(アクセッション番号AF114470)遺伝子のヌクレオチド679-708部位に結合(プローブは不完全一致の塩基配列)]
<プローブ3>
・5'-GCATCAGTAATCAGTTGTCAGAGGAGAAATTC-3':配列番号5
[32bp、C.albicans 18S rRNA(アクセッション番号AF114470)遺伝子のヌクレオチド758-790部位に結合(プローブは不完全一致の塩基配列)]
Specific IMQ probes are as follows.
<
-5'-CTTTCCTTCTGGGTAGCCATTT--3 ': SEQ ID NO: 3
[22bp, binds to nucleotides 585-607 of C.albicans 18S rRNA (accession number AF114470) gene (probe is incompletely matched nucleotide sequence)]
<
-5'-TGGAATAATAGAATAGGACGTTATGGTTC-3 ': SEQ ID NO: 4
[29bp, binds to nucleotides 679-708 of C.albicans 18S rRNA (accession number AF114470) gene (probe is incompletely matched nucleotide sequence)]
<
-5'-GCATCAGTAATCAGTTGTCAGAGGAGAAATTC-3 ': SEQ ID NO: 5
[32bp, binds to nucleotides 758-790 of C. albicans 18S rRNA (accession number AF114470) gene (probe is incompletely matched nucleotide sequence)]
本発明のカンジダ菌の同定方法の検出・同定感度は、1.2 CFU C.albicans/PCR Tubeである(図9)。
データベースに登録されたカンジダ8菌種の菌株を健常者血液に混入したカンジダ血症疑似血液検体を作成し、本発明方法にてカンジダ菌種の検出・同定を行った(図10)。
その結果、カンジダ8菌種全てで正確に同定することが出来た。
実際のカンジダ血症患者の血液検体15検体(3菌種)を用い、本発明方法にてカンジダ菌種の迅速同定を行った(図11)。
その結果、15検体全てにおいて、採血後3.5時間程度でカンジダ菌種を正確に検出・同定することが出来た。
The detection / identification sensitivity of the Candida identification method of the present invention is 1.2 CFU C. albicans / PCR Tube (FIG. 9).
A Candida blood pseudo blood sample was prepared by mixing 8 strains of Candida strains registered in the database into the blood of healthy subjects, and Candida species were detected and identified by the method of the present invention (FIG. 10).
As a result, it was possible to accurately identify all 8 Candida species.
Candida species were rapidly identified by the method of the present invention using 15 blood samples (3 species) of actual Candidaemia patients (FIG. 11).
As a result, it was possible to accurately detect and identify Candida species in about 15 hours after blood collection in all 15 specimens.
次に、本発明の不完全なマッチプローブを用いたカンジダ菌の同定法を実施例で説明する。
なお、本発明に係るプローブをIMQプローブ(imperfect-match quenching probes)と表現した。全体の流れ(ワークフロー)を図1に示す。
カンジダ株は、富山大学病院で患者の血液、喀痰および尿培養分離株からカンジダ株を得、それから配列決定して種レベルで同定した。
血液検体は、富山大学病院と流杉病院において、カンジダ血症患者から採取した全血であり、以下の実施例のすべての手技は、富山大学倫理委員会および流杉病院倫理委員会の承認並びにすべての患者から文書による同意を得て行われ、また実施例の方法は、承認されたガイドラインに従って実施された。
Next, a method for identifying Candida using the incomplete match probe of the present invention will be described in Examples.
The probe according to the present invention was expressed as an IMQ probe (imperfect-match quenching probes). The overall flow (workflow) is shown in FIG.
Candida strains were identified at the species level by obtaining Candida strains from patient blood, sputum and urine culture isolates at Toyama University Hospital and sequencing them.
Blood samples were whole blood collected from patients with Candidaemia at Toyama University Hospital and Nagasugi Hospital, and all procedures in the following examples were approved by Toyama University Ethics Committee and Nagasugi Hospital Ethics Committee and all The procedure was performed with written consent from the patient and the methods of the examples were performed according to approved guidelines.
<培養物からのカンジダDNAの抽出>
カンジダコロニーを滅菌接種ループで採取し、分子レベル等級の蒸留水(分子生物学のために脱イオンおよび滅菌した蒸留水、NACALAI TESQUE INC Kyoto Japan;以下、蒸留水)1mLに懸濁した。
その後、試料を20,000×gで10分間遠心分離し、ペレットを失わないように上清900μLを注意深く除去した。製品付属説明書の指示に従って、DNA抽出キット(QIAamp UCP Pathogen Mini Kit、Qiagen、Germany)およびガラスビーズを用いて、得られたペレットからDNAを単離した。最後に、100μLの溶出緩衝液でカンジダDNAを溶出させた。
<Extraction of Candida DNA from the culture>
Candida colonies were collected in a sterile inoculation loop and suspended in 1 mL of molecular grade distilled water (deionized and sterilized distilled water for molecular biology, NACALAI TESQUE INC Kyoto Japan; hereinafter distilled water).
The sample was then centrifuged at 20,000 × g for 10 minutes and 900 μL of supernatant was carefully removed so as not to lose the pellet. DNA was isolated from the resulting pellet using a DNA extraction kit (QIAamp UCP Pathogen Mini Kit, Qiagen, Germany) and glass beads according to the instructions in the product instructions. Finally, Candida DNA was eluted with 100 μL of elution buffer.
<全血からのカンジダDNAの抽出>
合計2mLの静脈血をEDTA-2Kチューブ(NIPRO Osaka Japan)に採血した。
次いで、血液サンプルを100×gで5分間遠心分離して血液細胞を遠心分離し、得られた上清画分(1mL)を使用した。
上清を再び20,000×gで10分間遠心分離し、上清画分900μLを慎重に除去してペレットを妨げないようにした。
次に、蒸留水1mLをペレットに加え、穏やかに上下逆さまにした後、20,000×gで5分間遠心分離した。
最後に、ペレットを再懸濁しないよう、上清画分1mLを注意深く取り除いた。
製品付属説明書の指示に従って、DNA抽出キットおよびガラスビーズを用いてペレットからDNAを単離した。
最後に、100μLの溶出緩衝液でカンジダDNAを溶出させた。
<Extraction of Candida DNA from whole blood>
A total of 2 mL of venous blood was collected into an EDTA-2K tube (NIPRO Osaka Japan).
The blood sample was then centrifuged at 100 × g for 5 minutes to centrifuge blood cells, and the resulting supernatant fraction (1 mL) was used.
The supernatant was again centrifuged at 20,000 × g for 10 minutes, and 900 μL of the supernatant fraction was carefully removed to avoid disturbing the pellet.
Next, 1 mL of distilled water was added to the pellet and gently turned upside down, followed by centrifugation at 20,000 × g for 5 minutes.
Finally, 1 mL of the supernatant fraction was carefully removed so as not to resuspend the pellet.
DNA was isolated from the pellet using a DNA extraction kit and glass beads according to the instructions in the product instructions.
Finally, Candida DNA was eluted with 100 μL of elution buffer.
<PCRアッセイ>
以下、標的DNAの増幅、リアルタイム検出、および不完全なマッチプローブのTm値分析のためにRotor-Gene Q(Qiagen)を使用した。
すべてのPCRアッセイは、1チューブに1PCR、1プローブのアッセイとして行った。
RNaseおよびDNaseフリー(Eppendorf、Germany)のPCR用0.2mLPCRチューブ(Qiagen)である1.5mLPCR専用エッペンドルフチューブを使用した。
公知の18SリボソームRNA遺伝子(18S rDNA)を標的とする真菌ユニバーサルプライマーを使用した(PLoS One. 2015;10:e0129032)。
多種の塩基配列アラインメントを作成するソフト(Clustal X)を用いてクエンチングプローブ(Qプローブ)を設計し、NIPPON STEEL SUMIKIN Eco-Tech Corporation(茨城、日本)において合成した。
<PCR assay>
In the following, Rotor-Gene Q (Qiagen) was used for target DNA amplification, real-time detection, and Tm value analysis of incomplete match probes.
All PCR assays were performed as 1 PCR, 1 probe assay per tube.
An Eppendorf tube dedicated to 1.5 mL PCR, which is a 0.2 mL PCR tube (Qiagen) for PCR of RNase and DNase free (Eppendorf, Germany), was used.
A fungal universal primer targeting the known 18S ribosomal RNA gene (18S rDNA) was used (PLoS One. 2015; 10: e0129032).
Quenching probes (Q probes) were designed using software (Clustal X) for creating various base sequence alignments and synthesized at NIPPON STEEL SUMIKIN Eco-Tech Corporation (Ibaraki, Japan).
<カンジダ菌属ユニバーサルプライマー>
・順方向:5'-CTTTCGATGGTAGGATAGTGG-3 '
[21bp、C.albicans 18S rRNA(アクセッション番号AF114470)遺伝子由来のヌクレオチド210-230]
・逆方向:5'-GCTTTCGCAGTAGTTAGTCTTC-3'
[22bp、C.albicans 18S rRNA(アクセッション番号AF114470)遺伝子由来のヌクレオチド802-823]
<Candida sp. Universal primer>
・ Forward: 5'-CTTTCGATGGTAGGATAGTGG-3 '
[21 bp, nucleotides 210-230 from
・ Reverse direction: 5'-GCTTTCGCAGTAGTTAGTCTTC-3 '
[22 bp, nucleotides 802-823 from
<プローブ1>
5'-CTTTCCTTCTGGGTAGCCATTT--3'
[22bp、C.albicans 18S rRNA(アクセッション番号AF114470)遺伝子のヌクレオチド585-607部位に結合(プローブは不完全一致の塩基配列)]
<プローブ2>
5'-TGGAATAATAGAATAGGACGTTATGGTTC-3'
[29bp、C.albicans 18S rRNA(アクセッション番号AF114470)遺伝子のヌクレオチド679-708部位に結合(プローブは不完全一致の塩基配列)]
<プローブ3>
5'-GCATCAGTAATCAGTTGTCAGAGGAGAAATTC-3'
[32bp、C.albicans 18S rRNA(アクセッション番号AF114470)遺伝子のヌクレオチド758-790部位に結合(プローブは不完全一致の塩基配列)]
<
5'-CTTTCCTTCTGGGTAGCCATTT--3 '
[22bp, binds to nucleotides 585-607 of C.albicans 18S rRNA (accession number AF114470) gene (probe is incompletely matched nucleotide sequence)]
<
5'-TGGAATAATAGAATAGGACGTTATGGTTC-3 '
[29bp, binds to nucleotides 679-708 of C.albicans 18S rRNA (accession number AF114470) gene (probe is incompletely matched nucleotide sequence)]
<
5'-GCATCAGTAATCAGTTGTCAGAGGAGAAATTC-3 '
[32bp, binds to nucleotides 758-790 of C. albicans 18S rRNA (accession number AF114470) gene (probe is incompletely matched nucleotide sequence)]
<PCR手順>
PCR用酵素は、KOD FX Neo(東洋紡)を使用した。
PCR反応混合物(50μL)は、KOD FX Neo、0.4mMのdNTP、および0.02Uの1×PCR緩衝液(KOD FX Neo:東洋紡、に付属)、0.2μMの順方向プライマー、0.6μMの逆方向プライマーおよび0.02μMの各プローブを含む。
各試料を95℃で5分間インキュベートし、次いで98℃で10秒間熱変性させ、57℃で30秒間アニーリングし、72℃で20秒間伸長し、82℃で2秒間の蛍光捕捉に供した。
以上のPCR条件で50サイクル実施した。
<PCR procedure>
KOD FX Neo (Toyobo) was used as the PCR enzyme.
The PCR reaction mixture (50 μL) consists of KOD FX Neo, 0.4 mM dNTP, and 0.02
Each sample was incubated at 95 ° C. for 5 minutes, then heat denatured at 98 ° C. for 10 seconds, annealed at 57 ° C. for 30 seconds, extended at 72 ° C. for 20 seconds, and subjected to fluorescence capture at 82 ° C. for 2 seconds.
50 cycles were carried out under the above PCR conditions.
<融点(Tm)値分析>
Tm値分析のために、得られたPCRアンプリコンに各プローブが入ったPCRチューブを95℃で10秒間加熱し、次いで40℃で90秒間冷却した。
PCR後のTm値分析を40℃~95℃で1℃/ステップで増加させて行った。
続いてデータプロフィールをRotor-Gene Qソフトウェアプログラムを用いて分析し、Tm値を同定した。
<Melting point (Tm) value analysis>
For Tm value analysis, the PCR tube containing each probe in the resulting PCR amplicon was heated at 95 ° C. for 10 seconds and then cooled at 40 ° C. for 90 seconds.
Tm value analysis after PCR was performed at 40 ° C. to 95 ° C. with an increase of 1 ° C./step.
The data profile was then analyzed using the Rotor-Gene Q software program to identify Tm values.
<分析感度試験>
カンジダ・アルビカンス(C. albicans)の1つのコロニーを、サブロー(Sabouraud)デキストロース寒天培地で48時間培養した後に表面からこすり落とし、リン酸緩衝溶液(PBS)に懸濁し、再び培地に撒いた。
カンジダ・アルビカンスの1つの菌株のみを確実に純培養するために、48時間後に第2の培地から再び1つのコロニーを掻き取り、PBSに懸濁し、10倍希釈した。
各希釈液をいくつかのアリコートに分けた。
コロニーの数(等価CFU / ml)を評価するために、サブローデキストロース寒天培地3枚に撒いた。
検出限界(LOD)は、PBS中のカンジダ・アルビカンスの既知の数を基にしてDNAを連続的に希釈し、各希釈サンプルのPCR検出の有無を測定することによって決定した。
<Analysis sensitivity test>
One colony of C. albicans was cultured on Sabouraud dextrose agar for 48 hours, then scraped off the surface, suspended in phosphate buffered saline (PBS), and seeded again in the medium.
To ensure pure culture of only one strain of Candida albicans, one colony was scraped again from the second medium after 48 hours, suspended in PBS and diluted 10-fold.
Each dilution was divided into several aliquots.
In order to evaluate the number of colonies (equivalent CFU / ml), the cells were plated on 3 sheets of Sabouraud dextrose agar.
The detection limit (LOD) was determined by serially diluting DNA based on a known number of Candida albicans in PBS and measuring the presence or absence of PCR detection in each diluted sample.
<真菌ゲノムDNAのヌクレオチド配列に基づく分析>
公知のD1-D2領域および内部転写スペーサー(ITS)領域を標的とする真菌プライマーを精製し(QIAquick PCR Puri cation Kit; QIAGEN)、次いでシークエンスにて配列決定した(3500 Genetic Analyzer; Applied Biosystems)。
菌種の同定は、DNAデータバンク(http://www.ddbj.nig.ac.jp/index-j.html)のBLASTヌクレオチドデータベースツールを用いて、菌種同定のためのオンライン・ヌクレオチド相同性検索を行った。
<Analysis based on nucleotide sequence of fungal genomic DNA>
Fungal primers targeting the known D1-D2 region and the internal transcription spacer (ITS) region were purified (QIAquick PCR Purification Kit; QIAGEN) and then sequenced (3500 Genetic Analyzer; Applied Biosystems).
Bacterial species identification is performed using the BLAST nucleotide database tool of DNA Data Bank (http://www.ddbj.nig.ac.jp/index-j.html) and online nucleotide homology for bacterial species identification I did a search.
<カンジダ種の培養に基づく生化学的同定>
同じ穿刺部位から採取した同じ検体のTm分析のために、全血液サンプル(1つの好気性血液培養ボトルおよび1つの嫌気性血液培養ボトル)を血液サンプルと同時に収集した。
そして、富山大学病院臨床検査センター(ISO15189認証)の標準的な方法に従って全血試料を分析した。
血液培養手順は、BacT/ALERT 3Dシステム(bioMerieux、Inc.、Mercy-l'Etoile、France)を用いて行った。
真菌の同定は、CHROMager Candida(Becton Dickinson and Company、USA)およびマトリックス支援レーザー脱離イオン化 - 飛行時間型(MALDI-TOF)質量分析(Bruker、USA)によって行った。
<Biochemical identification based on Candida species culture>
Whole blood samples (one aerobic blood culture bottle and one anaerobic blood culture bottle) were collected simultaneously with the blood sample for Tm analysis of the same specimen taken from the same puncture site.
The whole blood sample was analyzed according to the standard method of the Clinical Laboratory Center of Toyama University Hospital (ISO 15189 certification).
Blood culture procedures were performed using the BacT / ALERT 3D system (bioMerieux, Inc., Mercy-l'Etoile, France).
Fungal identification was performed by CHROMager Candida (Becton Dickinson and Company, USA) and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (Bruker, USA).
本発明のカンジタ菌の同定方法は、1つのPCRプライマーセットと3つの不完全なマッチプローブを使用して、3つのTm値を生成させ、それらをデータベースに登録されたデータと比較することにより、カンジダ症のカンジダ種(8種)を迅速に同定することができる。
同定に要する時間は、採血から3時間半以内である。
本発明の新たな遺伝子検査法は、迅速に加え、簡便・安価に実施可能であるため、体外診断薬としてキット化でき、医療上有用である。
The method for identifying Candida of the present invention uses one PCR primer set and three incomplete match probes to generate three Tm values and compare them with data registered in a database. Candidiasis (8 species) with candidiasis can be rapidly identified.
The time required for identification is within 3.5 hours after blood collection.
Since the new genetic testing method of the present invention can be carried out quickly and easily and inexpensively, it can be kitted as an in-vitro diagnostic agent and is medically useful.
Claims (5)
(1)血液などの検体からカンジタ菌のDNAを抽出する工程。
(2)抽出したカンジダ菌DNAを鋳型とし、カンジダ菌のユニバーサルプライマー1セットおよび不完全なマッチプローブ3種を用いてPCRを行う工程。
(3)不完全なマッチプローブの融解温度(Tm)値を取得する工程。
(4)Tm値をデータベースと照合する工程。 A method for identifying Candida, comprising the following steps (1) to (4):
(1) A step of extracting Candida DNA from a sample such as blood.
(2) A step of performing PCR using the extracted Candida bacteria DNA as a template and using one set of Candida universal primers and three incomplete match probes.
(3) A step of obtaining a melting temperature (Tm) value of an incomplete match probe.
(4) A step of checking the Tm value with a database.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020509569A JPWO2019187240A1 (en) | 2018-03-28 | 2018-09-28 | Rapid identification of Candida using an incomplete match probe |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018061350 | 2018-03-28 | ||
| JP2018-061350 | 2018-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019187240A1 true WO2019187240A1 (en) | 2019-10-03 |
Family
ID=68061062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2018/036323 Ceased WO2019187240A1 (en) | 2018-03-28 | 2018-09-28 | Method for rapid identification of candida in which incomplete match probes are used |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2019187240A1 (en) |
| WO (1) | WO2019187240A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023163664A3 (en) * | 2022-02-28 | 2023-10-26 | National University Of Singapore | A method of profiling a microbiotic composition |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06339399A (en) * | 1993-06-01 | 1994-12-13 | Hideyo Yamaguchi | Primer for pathogenic mycota gene amplification |
| JPH11508137A (en) * | 1995-08-17 | 1999-07-21 | エベルハルト−カルルス−ウニベアジテート、テュービンゲン | Extraction, amplification and sequential hybridization of fungal cell DNA and methods for detecting fungal cells in clinical substances |
-
2018
- 2018-09-28 JP JP2020509569A patent/JPWO2019187240A1/en not_active Ceased
- 2018-09-28 WO PCT/JP2018/036323 patent/WO2019187240A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06339399A (en) * | 1993-06-01 | 1994-12-13 | Hideyo Yamaguchi | Primer for pathogenic mycota gene amplification |
| JPH11508137A (en) * | 1995-08-17 | 1999-07-21 | エベルハルト−カルルス−ウニベアジテート、テュービンゲン | Extraction, amplification and sequential hybridization of fungal cell DNA and methods for detecting fungal cells in clinical substances |
Non-Patent Citations (7)
| Title |
|---|
| CHAKRAVORTY, SOUMITESH ET AL.: "Rapid Universal Identification of Bacterial Pathogens from Clinical Cultures by Using a Novel Sloppy Molecular Beacon Melting Temperature Signature Technique", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 48, no. 1, 2010, pages 258 - 267, XP055620382, DOI: 10.1128/JCM.01725-09 * |
| DATABASE Nucleotide [online] 25 March 1999 (1999-03-25), CANDIDA ALBICANS 18S RIBOSOMAL RNA GENE, COMPLETE SEQUENCE, XP055642058, retrieved from NCBI Database accession no. AF114470 * |
| HIGASHI,YOSHITSUGU ET AL: "Realization of Causative Strain Rapid 工dentification Test Method for Candidemia", PROGRAM AND ABSTRACTS OF THE 61ST ANNUAL MEETING OF THE JAPANESE SOCIETY FOR MEDICAL MYCOLOGY, 2017, pages P-04(0-4) * |
| KLEINSCHMIDT, K. ET AL.: "Development of a qualitative real-time PCR for microbiological quality control testing in mammalian cell culture production", JOURNAL OF APPLIED MICROBIOLOGY, vol. 122, no. 4, April 2016 (2016-04-01), pages 997 - 1008, XP055642056 * |
| LISCHEWSKI, AXEL ET AL.: "Specific detection of Candida albicans and Candida tropicalis by fluorescent in situ hybridization with an 18S rRNA-targeted oligonucleotide probe", MICROBIOLOGY, vol. 142, no. 10, October 1996 (1996-10-01), pages 2731 - 2740, XP001536330 * |
| NEEFS, JEAN-MARC ET AL.: "Compilation of small ribosomal subunit RNA structures", NUCLEIC ACIDS RESEARCH, vol. 21, no. 13, July 1993 (1993-07-01), pages 3025 - 3049, XP055642053 * |
| UENO, TOMOHIRO ET AL.: "Eukaryote-Made Thermostable DNA Polymerase Enables Rapid PCR-Based Detection of Mycoplasma, Ureaplasma and Other Bacteria in the Amniotic Fluid of Preterm Labor Cases", PLOS ONE, vol. 10, no. 6, 4 June 2015 (2015-06-04), pages e0129032, XP055642055 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023163664A3 (en) * | 2022-02-28 | 2023-10-26 | National University Of Singapore | A method of profiling a microbiotic composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2019187240A1 (en) | 2021-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110541022A (en) | mycobacterium tuberculosis complex detection kit based on CRISPR-Cas12a system | |
| CN102533959A (en) | Multiplex polymerase chain reaction (PCR) kit for identifying mycobacterium tuberculosis | |
| Nasr Esfahani et al. | Rapid and accurate identification of Mycobacterium tuberculosis complex and common non-tuberculous mycobacteria by multiplex real-time PCR targeting different housekeeping genes | |
| CN118207347B (en) | Rapid detection method for Haemophilus influenzae based on CRISPR-Cas12a system | |
| Kalaiarasan et al. | Diagnostic performance of real time PCR and MALDI-TOF in the detection of nontuberculous mycobacteria from clinical isolates | |
| Li et al. | Development and clinical implications of a novel CRISPR-based diagnostic test for pulmonary Aspergillus fumigatus infection | |
| EP2107114B1 (en) | Primer and probe for detection of mycobacterium avium and method for detection of mycobacterium avium by using the primer or probe | |
| US9816142B2 (en) | Compositions and methods for detection of Staphylococcus aureus | |
| CN112280878B (en) | A specific target, primer, detection method and application for detecting Vibrio parahaemolyticus | |
| CN111154900B (en) | New molecular targets specific to Pseudomonas aeruginosa and their rapid detection methods | |
| CN107083443A (en) | One group is used for the primer combination that meningitis sepsis Elizabethan bacterium PCR is detected | |
| Elgaml et al. | Analysis of 16S ribosomal RNA gene segments for the diagnosis of Gram negative pathogenic bacteria isolated from urinary tract infections | |
| WO2019187240A1 (en) | Method for rapid identification of candida in which incomplete match probes are used | |
| CN116121426B (en) | A primer set, kit and method for detecting Mycobacterium tuberculosis by loop-mediated isothermal amplification | |
| KR101765677B1 (en) | Primer set for detection of mycobacterium tuberculosis and non-Tuberculosis mycobacteria and use thereof | |
| JP2009039105A (en) | Oligonucleotide for detection of mycobacteria and use thereof | |
| CN108060244A (en) | A kind of nucleotide sequence and application for mycobacterium tuberculosis complex detection | |
| RU2639498C1 (en) | Set of oligonucleotide primers and fluorescence marked probes for identifying of blastomycesis dermatitis irritant | |
| JP4477741B2 (en) | Method for detecting Mycoplasma and Ureaplasma bacteria and method for identifying Mycoplasma and Ureaplasma species | |
| JP5097785B2 (en) | Identification method of Mycoplasma and Ureaplasma species | |
| CN120099202B (en) | Specific molecular marker for screening staphylococcus xylosus, primer group and application | |
| CN119842946B (en) | A CRISPR/Cas12b-based method for detecting Neisseria gonorrhoeae | |
| CN119753187B (en) | A primer-probe combination for identifying mycobacterial species, a kit, and an identification method and application thereof | |
| RU2819877C1 (en) | Test system for rapid detection and identification of mycobacterium avium complex | |
| CN110512013B (en) | Method for identifying three corynebacteria by using high-resolution melting curve method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18911800 Country of ref document: EP Kind code of ref document: A1 |
|
| ENP | Entry into the national phase |
Ref document number: 2020509569 Country of ref document: JP Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 18911800 Country of ref document: EP Kind code of ref document: A1 |